Will I have to mortgage my house? Reflections on gene therapy, innovation, and inequality in the USA
The first FDA-approved gene therapy, Kymriah, was released to the public in August 2017 with a $475,000 price tag. With the emergence of personalized genetic medicine, we are entering a new era of profound inequality. This talk explores the stories of children and parents who signed up for the Kymriah clinical trial before it was approved—risking their lives and household finances in pursuit of a cancer cure. Issues of race and class played out at Penn Medicine, as researchers explored new horizons of hope with living cellular therapies.
Date: 23 January 2023, 16:00 (Monday, 2nd week, Hilary 2023)
Venue: Maison Française d’Oxford, 2-10 Norham Rd, Oxford OX2 6SE
Speaker: Eben Kirksey (University of Oxford)
Organising department: Oxford Centre for the History of Science, Medicine and Technology
Part of: Oxford Centre for the History of Science Medicine & Technology (OCHSMT) Seminars and Events
Booking required?: Not required
Audience: Members of the University only
Editor: Belinda Clark